Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is involved in identifying, developing and commercialising novel, small molecule therapies for people with dermatological and immunological diseases. Operational in the biotechnology industry, Aclaris Therapeutics Inc focuses on providing solutions to multiple dermatological and immunological conditions through KINect, its drug discovery technology platform. The company’s product pipeline aims to target conditions such as rheumatoid arthritis, inflammatory bowel disease and pancreatic cancer. Aclaris Therapeutics Inc operates Confluence Discovery Technologies Inc as an indirect, wholly owned subsidiary. Add ACRS stock to your eToro virtual portfolio.